Cabot has added this emerging performance technology to its portfolio through an intellectual property licensing agreement with XG Sciences, Inc. Under the agreement, Cabot will license intellectual pproperty rights to XG's xGnP graphene nanoplatelets technology, including detailed know-how regarding the manufacturing process.
For more details on Cabot adds graphene to its portfolio click here
Friday, November 04, 2011
Cabot adds graphene to its portfolio
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment